During the past decade, Guiyang Public Health Treatment Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guiyang Public Health Treatment Center" are "Multidrug Resistant Tuberculosis" (5 trials), "Tuberculosis, Pulmonary" (2 trials), "Tuberculosis, Multidrug-Resistant" (1 trials) and "Tuberculosis; Pulmonary, Confirmed, Unspecified Means" (1 trials). Many other conditions were trialed in "Guiyang Public Health Treatment Center" in a lesser frequency.

Most popular intervention types in "Guiyang Public Health Treatment Center" are "Drug" (5 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bedaquiline" (2 trials), "Clofazimine" (2 trials), "Cycloserine" (2 trials), "Linezolid" (2 trials) and "Pyrazinamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Guiyang Public Health Treatment Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Guiyang Public Health Treatment Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Guiyang Public Health Treatment Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guiyang Public Health Treatment Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".